STEMPOINT CAPITAL
StemPoint looks to exploit the growing characteristics of the biotechnology sector and the protective attributes of the pharmaceutical industry.
Similar Organizations
EnviroKure, Incorporated
Disruptive ag biotechnology to enhance plant growth and productivity, builds healthy soil and can reduce the need for chemical fertilizers.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Vallon Pharmaceuticals
Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company.
Investors List
Leucadia Asset Management
Leucadia Asset Management investment in Venture Round - StemPoint Capital
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-04-05 | Protara Therapeutics | StemPoint Capital investment in Post-IPO Equity - Protara Therapeutics | 45 M USD |
| 2024-04-01 | Surrozen | StemPoint Capital investment in Post-IPO Equity - Surrozen | 17.5 M USD |
| 2024-02-27 | Pyxis Oncology | StemPoint Capital investment in Post-IPO Equity - Pyxis Oncology | 50 M USD |
| 2024-01-22 | Dianthus Therapeutics | StemPoint Capital investment in Post-IPO Equity - Dianthus Therapeutics | 230 M USD |
| 2023-12-15 | AC Immune | StemPoint Capital investment in Post-IPO Equity - AC Immune | 50.05 M USD |
| 2023-10-19 | Tourmaline Bio | StemPoint Capital investment in Post-IPO Equity - Tourmaline Bio | 75 M USD |
More informations about "StemPoint Capital"
StemPoint Capital
StemPoint Capital LP 520 Madison Avenue, 19th Floor New York, NY 10022 [email protected]See details»
StemPoint Capital - Crunchbase Investor Profile
StemPoint Capital invests in post-IPO equity in biotechnology, healthcare, and therapeutics sectors, focusing on North American hubs like New York, South San Francisco, and Boston. Learn More. Similar Investments. Enavate Sciences . …See details»
StemPoint Capital - Investments, Portfolio & Company Exits
StemPoint Capital 's most notable exits include Pyxis Oncology, Dianthus Therapeutics, and Tourmaline Bio. Which industries has this organization had the most exits in? Show . Pyxis …See details»
STEMPOINT CAPITAL LP Top 13F Holdings - WhaleWisdom.com
Sep 30, 2024 Stempoint Capital is a large advisory firm with 4 clients and discretionary assets under management (AUM) of $440,900,000 (Form ADV from 2024-09-27). Their last reported …See details»
Hedge Fund - StemPoint Capital - Insider Monkey
StemPoint Capital, founded by Michelle Ross, specializes in a long-biased, biopharma-focused, long/short equity strategy. The firm employs a fundamental, science-driven research process …See details»
StemPoint Capital LP Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for StemPoint Capital LP of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
StemPoint Capital LP Top Holdings 13F Filings - Holdings Channel
As of 09/30/2024, below is a summary of the Stempoint Capital LP top holdings by largest position size, as per the latest 13f filing made by Stempoint Capital LP. In the Stempoint Capital LP-top …See details»
StemPoint Capital LP - LinkedIn
StemPoint Capital LP | 96 followers on LinkedIn. StemPoint Capital LP is a global life science equity focused investment manager founded in 2022. StemPoint is headquartered in New York …See details»
StemPoint Capital - Products, Competitors, Financials, Employees ...
StemPoint Capital LP grew its position in Fulcrum Therapeutics by 8.1% in the first quarter. StemPoint Capital LP now owns 407,108 shares of the company’s stock valued at $3,843,000 …See details»
StemPoint Capital - Funding, Financials, Valuation & Investors
Jan 19, 2023 StemPoint Capital has raised 1 round. This was a Venture - Series Unknown round raised on Jan 19, 2023 . StemPoint Capital is funded by Leucadia Asset Management .See details»
StemPoint Capital Announces Strategic Relationship with Leucadia …
Jan 19, 2023 Media Inquiries: StemPoint Capital Sean Tan 212-540-4099 [email protected] Leucadia Asset Management / Jefferies Financial Group …See details»
Stempoint Capital 13F filings and top holdings and stakes - stockzoa
SEC 13F filings are viewable for Stempoint Capital going back to 2024. Stempoint Capital 2024 Q3 filed Nov. 13, 2024 Stempoint Capital 2024 Q2 restated filed Aug. 13, 2024 Stempoint …See details»
Stempoint Capital Lp 13F Portfolio - HedgeFollow
Fund Portfolio Manager Performance 24Q3 AUM # of Holdings Performance Rank Allocation ; Stempoint Capital Lp: Stempoint Capital Lp: 8.23%: $334091000: 50: N/ASee details»
STEMPOINT CAPITAL LP - 13F
Stempoint Capital LP reported 54 holdings with total value $334 M as of Q3 2024. Top holdings included SNDX, ROIV, MRUS, IMVT, and ARQT. STEMPOINT CAPITAL LP 13F Portfolio …See details»
StemPoint Capital Fund News | Hedge Fund Research
Jan 24, 2024 StemPoint Capital Fund is a Hedge Fund in New York, that has raised $48.85 mm from 19 investors, for an equity fund started in Dec 2022. Data from SEC filing on 24 Jan …See details»
STEMPOINT CAPITAL LP | Form ADV - Radient
Firm Details for STEMPOINT CAPITAL LP, Location: New York, AUM = 440900000.00, Last Form ADV Filed : 27-September-2024, Officers: TAN, SEAN, CHUA, TAN, SEAN, CHUA, …See details»
StemPoint Capital Announces Strategic Relationship with Leucadia …
Jan 19, 2023 About StemPoint Capital. StemPoint was founded and officially launched on January 3, 2023, by Michelle Ross, the Chief Investment Officer and Managing Partner. …See details»
StemPoint Capital Announces Strategic Relationship with Leucadia …
01/19/2023 - 11:08 AM . NEW YORK--(BUSINESS WIRE)-- StemPoint Capital LP (“StemPoint”), a long-biased equity asset management firm dedicated to the global life sciences industry, …See details»
Venture Round - StemPoint Capital - 2023-01-19 - Crunchbase
Jan 19, 2023 StemPoint Capital raised an undisclosed amount on 2023-01-19 in Venture RoundSee details»
STEMPOINT CAPITAL LP Schedule 13G Filing Concerning SRZN on …
Nov 1, 2024 STEMPOINT CAPITAL LP Total Shares: 428k. Subject Company: Surrozen, Inc View Complete Ownership History. Backtest Filed as of Date: 2024-11-01: Event Date: 2024 …See details»